Table 1.
S No | "Author,Year, Study, Design" | Type of treatment | "PatientDetailsSex/Age" | Sample Size | Curcumin Formulations | Dosage &Directions | Results-Clinical Improvement | Therapy Duration | Adverse Effects | Outcome measures | Grading Scale |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Suresh Rao et al 2014,Single-blinded, randomized controlled clinical trial | Radiotherapy/Radio-chemotherapy | 26-85 years Males-64 Females-16 | 80 Adults,Group1-40,Group2-40 | "Turmeric gargleVsPovidone-iodine" | Turmeric gargle -10 ml,2min,6 times a day.Povidone Iodine-1:100,10ml 2times a day | Decreased intolerable mucositis (P < 0.0001) Lesser incidence of treatment breaks before 4 weeks (P < 0.01) and reduced change in body weight (P < 0.001). | 6 weeks | No side-effects | Gargling with turmeric delayed and reduced the severity of mucositis | RTOG |
2 | Mansourian et al 2015 ,Double blind,placebo-controlled randomized clinical trial | Radiotherapy | Males-31,Females-6 | 37 Adults | Curcuma longa gel Vs Placebo topical gel | "Gelwas applied for all radiotherapy duration (21 days) 3 times a day,15 min before initiation" | "Erythema-;Case Group-4.9 mm Control Group-8.9 mm;Ulcer-;Case Group-1.3mm; Control group-7.9mm" | 8 weeks | Nausea after using gel, got resolved after 2 weeks | "Curcuma Longa improves the grade ofmucositis and reduces the size of oral lesions" | WHO,VAS |
3 | "Karthikeya Patil et al ,2015; Randomised; Controlled clinical trial" | Radio-chemotherapy | 39-70 years,Males-11,Females-9 | 20 Adults,Group 1-10,Group 2-10 | "Chlorhexidine mouthwash VsFreshly prepared curcumin mouthrinse" | Group 1-Chlorhexidine mouthwash 0.2%,1:1,1 min, Thrice daily.Curcumin Mouthrinse 0.0004%,1;5,1min ,thrice daily | Statistically significant difference was found in the NRS (p<0.001), Erythema (p=0.050), ulceration (p<0.001) and WHO scores (p=0.003) between the two groups. | 20 days | No side-effects | Curcumin was better than chlorhexidine mouth wash in rapid wound healing, better patient compliance in management of oral mucositis. | "WHO Scale,OMAS,NRS" |
4 | "Charanthimath ,2016 Randomised; controlled clinical trial; Randomised; controlled clinical trial" | Radio-chemotherapy | _ | 40 Adults,Group A-20,Group B-20 | Curcumin gel Vs Chlorhexidine gel | Group A-Curcumin gel,Group B-Chlorhexidine gel | "Change in ErythemaGroup A- 100% , Group B-57.7%;Size of Ulcer reductionGroup A-103.4%;Group B-53.6% " | 2 weeks | No side-effects | Curcumin gel is an effective and safer alternative to chlorhexidine gel in treatment of oral mucositis | "NRS,OMAS,WHO Mucositis scale" |
5 | "Zahra Delavarian et al,2019Double-blind randomised clinical Trial" | Radiotherapy | Study-62.18+-15.07,Control-55.87+-15.33Females-13; Males-19 | "Study Group-16Control Group-16" | "Nanocurcumin Vs Placebo(Lactose)" | 1 capsule 80mg/day oral Nanocurcumin(1 capsule of sincurcumin 80mg /day | Statistically significant difference in the severity of mucositis between 2 groups at all visits. | "Day 0,7, 14, 21, 28, 35, 42" | No oral/systemic side effects | Nanomicelle curcumin is an effective agent in prevention of oral mucositis. | NCI-CTC v.2 |
S No | "Author,Year, Study, Design" | Type of treatment | "PatientDetailsSex/ Age" | Sample Size | Curcumin Formulations | Dosage &Directions | Results-Clinical Improvement | Therapy Duration | Adverse Effects | Outcome measures | Grading Scale |
6 | "Arun P et al,2020Randomised placebo controlled trial" | Radio-Chemotherapy | "30-90years;Male-28;Female-33;" | "Group A-30Group B -31" | Turmeric extract capsule Vs Placebo | "Group A-500mg turmeric extract thrice dailyGroup B-Placebo" | 73.3% had grade 1 mucositis after 4 weeks of treatment. Difference is statistically significant from 3 weeks onwards(p<0.0001) | 2 months | No side effects | Turmeric extract reduces the incidence and severity of radiation-induced mucositis. | "WHO,NCI CTCAE" |
7 | Shah et al 2021, Randomised,Parrallel arm, triple-blinded controlled clinical trial | Radiotherapy | "26-96 yearsMales-54Females-14" | "MIT-Control Group-35Study Group- 33PP-Control Group-9Study Group- 8" | Benzydamine 0.15% mouthwash, Curcumin 0.1% mouthwash, | 10ml mouthwash thrice daily for 7 days, freshly prepared for 6 visits.(weekly) | Both mouthwashes were effective in delaying onset and preventing severe RIOM. | 6 weeks | Burning sensation in 1 patient | 0.1%Curcumin mouthwash significantly delay the onset of RIOM. | WHO |
8 | "Meghna Adhvaryu et al 2018Case controlled open labelled controlled Trial" | Radiotherapy/Radio-chemotherapy | "10-90 years;Males-174Females-30" | "Group 1-95 ControlGroup 2-109Trial group" | "Conventional Radio-chemotherapy, Oral Curcumin" | Control group -Conventional radio-chemotherapy Trial group -650 mg of oral curcumin fortified with 13mg of piperine /day +conventional therapy for 2 months 3 times/day starting from 3 days before planned radiation. | Significant reduction in incidence of mucositis from 92% to 51% (P ≤ 0.001) Grade III and IV mucositis from 51.6% to 12.8% (P≤ 0.001) | 2 months | Mild stomach upset in 10%cases | Curcumin showed a adjuvant protective activity to radio-chemotherapy in HNCP. | WHO |
9 | "Saldanha et al2014;Quasi experimental pre-post intervention design" | Radiotherapy/Radio-chemotherapy | "31-75 yearsMale-32Female-8" | "40 Adults Group I-20 Group II-20 " | "Turmeric Mouth Wash VsSaline Mouth wash " | "50ml freshly prepared Turmeric mouthwash,Thrice daily for 5 days" | "Reduction in mean scoresPreday=25.4Postday=18.9" | 5 days | No-side effects | Turmeric mouth wash was better than saline mouth wash. | "Oral mucositis Assessment checklistPain Scale" |
MITو Modified Intention to Treat; PP, Per Protocol Analysis ; Visual Analog Scale(VAS), Numeric Rating Scale(NRS), Radiotherapy Oncology Group (RTOG), World Health Association (WHO) scales, Oral Mucositis Assessment Scale (OMAS), National Cancer Institute Common Toxicity Criteria version 2 scale (NCI-CTC v.2), National Cancer Institute Common Terminology Criteria for Adverse Events, version 4.0(NCI CTCAE assessment V.4, Radiation Induced Oral Mucositis(RIOM),RCT-Radio-chemotherapy,RT-Radiotherapy